首页> 外文期刊>Annals of Medicine and Surgery >Total tumor volume as a prognostic value for survival following liver resection in patients with hepatocellular carcinoma. Retrospective cohort study
【24h】

Total tumor volume as a prognostic value for survival following liver resection in patients with hepatocellular carcinoma. Retrospective cohort study

机译:肝细胞癌患者肝切除后肝切除术后的总肿瘤体积作为存活率的预后价值。回顾性队列研究

获取原文
           

摘要

BackgroundTotal tumor volume (TTV) can provide a simplified parameter in describing the tumor burden by incorporating the size and number of tumor nodules into one continuous variable. The aim of the study was to evaluate the prognostic value of TTV in resection of hepatocellular carcinoma (HCC).MethodsPatients who underwent liver resection for HCC between 2012 and 2017 were retrospectively analyzed. Patients were divided into a group with TTV ≤65.5?cm3 (which nearly equal to a single tumor with a diameter of 5?cm), and another group with TTV?>?65.5?cm3.ResultsTwo hundred and four patients were included in this study (108 patients had TTV?≤?65.5cm3, and 96 patients had TTV?>?65.5?cm3). Ninety patients (44.1%) were within Milan and 114 patients (55.9%) were beyond Milan criteria. Eighteen patients (15.8%) of beyond Milan criteria had TTV?≤?65.5?cm3, with a median survival of 32 months which is comparable to a median survival of patients with TTV< 65.5?cm3 (38 months,P?=?0.38). TTV-based Cancer of Liver Italian Program (CLIP) score gained the highest value of likelihood ratio 114.7 and the highest Concordance-index 0.73 among other prognostic scoring and staging systems. In multivariate analysis, independent risk factors for diminished survival were serum AFP level >400?ng/ml, TTV >65.5?cm3, microvascular invasion, postoperative decompensation (allPvalues?
机译:背景技术肿瘤体积(TTV)可以通过将肿瘤结节的尺寸和数量掺入一个连续变量来提供简化的参数来描述肿瘤负担。该研究的目的是评估TTV在切除肝细胞癌(HCC)中的预后值。回顾性分析了2012年和2017年肝切除肝切除的方法。将患者分成TTV≤65.5?cm 3的基团(几乎等于直径为5Ω·cm的单个肿瘤),另一组含有TTV?> 65.5?CM3.Resultstwo百分之一患者研究(108名患者有TTV?≤α≤65.5cm3和96名患者有TTV?>?65.5?cm3)。九十名患者(44.1%)在米兰和114名患者(55.9%)之外,超出了米兰标准。超越米兰标准的十八名患者(15.8%)具有TTV?≤α65.5?CM3,中位生存期为32个月,与TTV患者的中位存活率相当(38个月,P?= 0.38 )。基于TTV的肝脏意大利计划(CLIP)评分获得了最高值为114.7的最高值114.7,以及其他预后评分和分期系统中的最高一致性指数0.73。在多变量分析中,减少存活的独立危险因素是血清AFP水平> 400?Ng / ml,TTV> 65.5?CM3,微血管侵袭,术后失代偿(AllpValues?<?0.05).conclusionttv是描述肿瘤的可行预后措施HCC患者的负担。 TTV-Clip评分可以为HCC切除而不是其他分期系统提供良好的预后值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号